Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-03-11

Clinical Trial Update: Study to Evaluate Efficacy and Safety of Pulmicort Respules in Japanese Adult Asthmatic Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of Pulmicort Respules in Japanese adult asthmatics has completed, with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pulmicort Respules (budesonide)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2011-03-11